Sanofi SA (ADR)


Sanofi Snaps Up Tidal Therapeutics For $160M

Sanofi acquired Tidal Therapeutics, a privately held biotechnology company on Friday for an upfront payment of $160 million. The company will pay another …

Regeneron Pharmaceuticals Inc (REGN) and Sanofi SA (SNY) Announce New Positive Praluent® Phase 3 Data

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that, in a new pooled analysis of heterozygous familial hypercholesterolemia (HeFH) patients included in …

Ligand Pharmaceuticals Inc. (LGND) Enters into Commercial License and Supply Agreement with Sanofi SA (SNY) for Captisol-enabled SAR-125844

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) announces it has entered into a global license and supply agreement with Sanofi SA (ADR) (NYSE:SNY) to utilize Captisol in …

Canaccord Reiterates Buy on Regeneron Pharmaceuticals Inc (REGN) Following New Collaboration with Sanofi

In a research report released Tuesday, Canaccord analyst John Newman reiterated a Buy rating on Regeneron Pharmaceuticals Inc (NASDAQ:REGN) with a price target of …

Company Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc and Sanofi SA (ADR) Launch Major New Immuno-Oncology Collaboration

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR)(NYSE:SNY) have entered into a new global collaboration to discover, develop and commercialize new antibody cancer treatments …

Company Update (NASDAQ:REGN): Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that the European Medicine Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) …

Stock Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc and Sanofi SA (ADR) Announce Phase 3 Results From ODYSSEY JAPAN trial

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that the Phase 3 ODYSSEY JAPAN trial of the investigational therapy Praluent® (alirocumab) Injection …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts